WealthTrust Axiom’s La Jolla Pharmaceutical Company LJPC Stock Holding History

WealthTrust Axiom’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-25,400	Closed	-$81K	–	259
2022 Q2	$81K	Hold	25,400	–	–	0.03%	226
2022 Q1	$108K	Hold	25,400	–	–	0.03%	243
2021 Q4	$118K	Hold	25,400	–	–	0.04%	237
2021 Q3	$101K	Hold	25,400	–	–	0.03%	236
2021 Q2	$108K	Sell	25,400 -5,000	-16%	-$21.4K	0.03%	247
2021 Q1	$128K	Buy	+30,400	New	+$167K	0.04%	227

WealthTrust Axiom's LJPC Position: Q3 2022 in Review

WealthTrust Axiom sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 25,400 shares — an estimated $81K sold.

WealthTrust Axiom first reported a position in LJPC in Q1 2021 and held it in 6 quarters. The position peaked at $128K in Q1 2021. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.

WealthTrust Axiom reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
WealthTrust Axiom sold 25,400 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $81K.
WealthTrust Axiom first reported a position in La Jolla Pharmaceutical Company in Q1 2021 and held it in 6 quarters.
WealthTrust Axiom's La Jolla Pharmaceutical Company position peaked at $128K in Q1 2021.
0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.

Based on WealthTrust Axiom's 13F filing for Q3 2022, filed 3 Nov 2022.